Side effects of therapy of hepatitis C and their management
Author:
Funder
National Heart, Lung, and Blood Institute, National Institutes of Health
Publisher
Wiley
Subject
Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1053/jhep.2002.36810/fullpdf
Reference61 articles.
1. Afdhal NH Geahigan T Supporting the patient with chronic hepatitis during treatment Koff RS Wu GY Clinical Gastroenterology: Diagnosis and Therapeutics Totowa, NJ Humana Press 211 232
2. Safety of combination interferon alfa-2b/ribavirin therapy in chronic hepatitis C-relapsed and treatment-naive patients;Maddrey;Semin Liver Dis,1999
3. Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C;McHutchison;Semin Liver Dis,1999
4. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT);Poynard;Lancet,1998
5. Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group;Glue;Clin Pharmacol Ther,2000
Cited by 551 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Results from a retrospective case finding and re-engagement exercise for people previously diagnosed with hepatitis C virus to increase uptake of directly acting antiviral treatment;BMC Public Health;2024-09-06
2. Intranasal neomycin evokes broad-spectrum antiviral immunity in the upper respiratory tract;Proceedings of the National Academy of Sciences;2024-04-22
3. A Profound Insight into the Structure-activity Relationship of Ubiquitous Scaffold Piperazine: An Explicative Review;Medicinal Chemistry;2024-01
4. Biology of Anemia: A Public Health Perspective;The Journal of Nutrition;2023-11
5. Cytokines and their role as immunotherapeutics and vaccine Adjuvants: The emerging concepts;Cytokine;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3